Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy. | Pharmacoeconomics;19(1): 95-104, 2001 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy.

Caro, J J; O'Brien, J A; Migliaccio-Walle, K; Raggio, G.

Affiliation

Caro JJ; Caro Research, Concord, Massachusetts, USA. jcaro@caroresearch.com

Pharmacoeconomics ; 19(1): 95-104, 2001 Jan.

Article in En | MEDLINE | ID: mdl-11252549

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / HIV Infections / Indinavir / Anti-HIV Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / HIV Infections / Indinavir / Anti-HIV Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2001 Document type: Article Affiliation country: Country of publication: